Patent Application
Utility
App. No. 16/564,922
· Confirmation No. 6038
DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
Applicant:
Endo Pharmaceuticals Solutions Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-09-02 | ABN |
Abandonment | 2 | View | |
| 2021-05-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-05-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-12-24 | CTFR |
Final Rejection | 10 | View | |
| 2020-12-24 | 892 |
List of references cited by examiner | 1 | View | |
| 2020-12-24 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2020-12-24 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2020-12-24 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2020-12-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-12-02 | FOR |
Foreign Reference | 59 | View | |
| 2020-12-02 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-12-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-12-02 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-11-30 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-11-30 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-11-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-11-30 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2020-11-30 | CLM |
Claims | 2 | View | |
| 2020-11-30 | REM |
Applicant Arguments/Remarks Made in an Amendment | 8 | View | |
| 2020-11-30 | DIST.E.FILE |
Terminal Disclaimer-Filed (Electronic) | 3 | View | |
| 2020-11-30 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-11-30 | DISQ.E.FILE |
Terminal Disclaimer-Electronic-Approved | 1 | View | |
| 2020-11-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-09-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-09-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-09-21 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-06-29 | CTNF |
Non-Final Rejection | 15 | View | |
| 2020-06-29 | 892 |
List of references cited by examiner | 1 | View | |
| 2020-06-29 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2020-06-29 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2020-06-29 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-06-29 | 1449 |
List of References cited by applicant and considered by examiner | 20 | View | |
| 2020-06-15 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2020-06-15 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-06-15 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-02-03 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-02-03 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-02-03 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2019-12-26 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2019-12-18 | CTRS |
Requirement for Restriction/Election | 4 | View | |
| 2019-09-20 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-09-20 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-09-20 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2019-09-09 | ADS |
Application Data Sheet | 9 | View | |
| 2019-09-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-09-09 | PA.. |
Power of Attorney | 2 | View | |
| 2019-09-09 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-09-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 11 | View | |
| 2019-09-09 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 20 | View | |
| 2019-09-09 | SPEC |
Specification | 49 | View | |
| 2019-09-09 | CLM |
Claims | 3 | View | |
| 2019-09-09 | ABST |
Abstract | 1 | View | |
| 2019-09-09 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 45 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 29 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 27 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 11 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 37 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 36 | View | |
| 2019-09-09 | FOR |
Foreign Reference | 7 | View | |
| 2019-09-09 | OATH |
Oath or Declaration filed | 4 | View | |
| 2019-09-09 | DRW |
Drawings-only black and white line drawings | 21 | View | |
| 2019-09-09 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2019-09-09 | A.PE |
Preliminary Amendment | 1 | View | |
| 2019-09-09 | SPEC |
Specification | 1 | View | |
| 2019-09-09 | CLM |
Claims | 3 | View | |
| 2019-09-09 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View |
Inventors
Petr Kuzma
Princeton, NJ
Stephanie Decker
Princeton, NJ
Attorneys & Agents of Record
Classification
USPC
514/1.1
A61K9/0024
A61K38/12
A61P27/02
A61P37/00
A61P27/06
A61P5/08
A61P1/18
A61P17/00
A61P19/02
A61P31/18
A61P3/10
A61P9/12
A61P1/00
A61P5/06
A61P11/00
A61P1/04
A61P25/06
A61P35/00
A61K38/31
A61K47/32
A61K47/34
Prosecution
- Examiner
- REYNOLDS, FRED H
- Art Unit
- 1658
- Customer No.
- 23122
- Docket No.
- EPSI-106US3
- Confirmation No.
- 6038
Publication
- Pub. No.
- US20190388500A1
- Pub. Date
- 2019-12-26
Parent
is a Continuation of
→
App. 15/246,009
Filed 2016-08-24
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 12/814,286
Filed 2010-06-11
· Abandoned -- After Examiner's Answer or Board of Appeals Decision
Parent
is a Division of
→
App. 12/171,999
· US 7,759,312
Filed 2008-07-11
· Patented Case
Parent
is a Continuation in-part of
→
App. 11/372,749
· US 7,452,868
Filed 2006-03-10
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/660,930
Filed 2005-03-11
· Provisional Application Expired
Child
is a Continuation of
→
App. 18/428,462
Filed 2024-01-31
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 19/016,892
Filed 2025-01-10
· Docketed New Case - Ready for Examination
Child
is a Continuation of
→
App. 18/784,147
Filed 2024-07-25
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/986,278
Filed 2022-11-14
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/129,531
Filed 2023-03-31
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/328,385
Filed 2021-05-24
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/676,494
Filed 2022-02-21
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/496,352
Filed 2021-10-07
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/847,830
Filed 2022-06-23
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/237,644
Filed 2023-08-24
· Abandoned -- Incomplete Application (Pre-examination)
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH HOLDINGS, LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.),
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-26
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR PHARMACEUTICAL COMPANIES, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-25
from
ASTORA WOMEN'S HEALTH, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES LLC,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
ENDO PHARMACEUTICALS, INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-04-06
from
ASTORA WOMEN'S HEALTH, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES LLC,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
ENDO PHARMACEUTICALS, INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-04-06
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/564,922
- Filed
- 2019-09-09
- Pub. No.
- US20190388500A1
- Examiner
- REYNOLDS, FRED H
- Art Unit
- 1658
External Links